Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis
2010 ◽
Vol 95
(2)
◽
pp. 578-585
◽
2015 ◽
Vol 30
(suppl_3)
◽
pp. iii207-iii207
2012 ◽
Vol 2012
◽
pp. 11-12